Your body runs on a molecule most people have never heard of. Nicotinamide adenine dinucleotide, or NAD+, sits at the center of how your cells produce energy, repair damaged DNA, and defend against the wear that accumulates year after year. The problem is that NAD+ levels drop steadily as you age, which can link to anything from sluggish metabolism to diminished cognitive sharpness.
At PHASE Plastic Surgery & Longevity, led by board-certified plastic surgeon and longevity medicine expert Dr. Richard Baxter, Niagen® NR IV infusions in Seattle offer a direct, science-backed method for replenishing this critical coenzyme and supporting the way your body functions at its most fundamental level.
Why Deliver Nicotinamide Riboside Intravenously?
Nicotinamide riboside, or NR, is a precursor that your body converts into NAD+ after it enters your cells. In fact, direct infusions of NAD+ are less effective because the NAD+ has to be converted in NR before it can be taken up by the cell, and circulating NAD+ is a signal of inflammation. Oral NR supplements can help, but the digestive process breaks down a significant portion before it ever reaches circulation. Our Seattle patients may opt for a Niagen® NR IV infusion, which sidesteps this bottleneck entirely and delivers the compound straight into the system for more efficient uptake.
Once NAD+ levels rise, the downstream effects touch multiple systems at once. Mitochondria, the structures inside your cells responsible for generating energy, begin to operate more efficiently. Sirtuins, a group of proteins that regulate inflammation and stress response, become more active.
If you are serious about biohacking longevity at the cellular level rather than pursuing surface-level fixes, this kind of targeted intervention can have a significant impact.
What a Session Looks Like at PHASE Plastic Surgery & Longevity
You will sit comfortably in a chair in the medical office, and a trained clinician will start your IV line. The infusion runs between 30 minutes and an hour, depending on the protocol Dr. Baxter has mapped out for you.
Some Seattle patients notice an immediate uptick in mental clarity or energy after a Niagen® NR IV infusion. Others describe the effects as more gradual, building over a series of sessions. Dr. Baxter may recommend NR infusions on their own or combine them with a broader longevity plan alongside therapeutic plasma exchange, peptide therapies, or prescription interventions such as rapamycin and metformin. Your care plan depends on your bloodwork, health history, and goals.
What Makes Our Practice Different?
Seattle has no shortage of clinics marketing anti-aging services, but Dr. Baxter operates from a different starting point. He was the first in the plastic surgery field to bring the Circulate therapeutic plasma exchange protocol directly to Seattle patients, and he applies that same clinical rigor to NR IV therapy.
His focus is the biotech side of age reversal, rooted in peer-reviewed research and clinical trial outcomes rather than generalized wellness packages. The infusion takes place in a supervised medical setting within the practice, so we can immediately address any questions that come up during or after your session.
Reach Out To Learn More About Niagen® NR Infusion Therapy in Seattle
Aging at the cellular level is not something you have to accept passively. Targeted NAD+ restoration through Niagen® NR IV therapy gives you a concrete, evidence-based tool for supporting the biological machinery that keeps you sharp, energized, and resilient. Dr. Baxter and the PHASE Plastic Surgery & Longevity team are among a small number of providers nationwide bringing this caliber of longevity science directly to their patients.
If you are ready to explore Niagen® NR IV infusions in Seattle, contact our office to schedule a consultation. We are here to help you invest in how you age, starting now.
Sources:
Mehmel, M., Jovanović, N., & Spitz, U. (2020). Nicotinamide Riboside—The Current State of Research and Therapeutic Uses. Nutrients, 12(6), 1616. https://doi.org/10.3390/nu12061616
Rajman, L., Chwalek, K., & Bhatt, D. P. (2018). Therapeutic Potential of NAD-Boosting Molecules. Cell Metabolism, 27(3), 529–547. https://doi.org/10.1016/j.cmet.2018.02.011
Jessie Hawkins, Rebecca Idoine, Jun Kwon, Andrew Shao, Elizabeth Dunne, Elizabeth Hawkins, Kayla Dawson, Yasmeen Nkrumah-Elie. Randomized, placebo-controlled, pilot clinical study evaluating acute Niagen®+ IV and NAD+ IV in healthy adults medRxiv 2024.06.06.24308565; doi: https://doi.org/10.1101/2024.06.06.24308565
N/a